The current lack of harmonisation of malaria vaccine assay conduct coupled with the lack of an enabling environment for comparing research results leads to scepticism about the comparability of assay results. Assay harmonisation is a central priority to enable rational malaria vaccine design and for decision-making in vaccine development.
The overall goal of this three year project is to develop harmonised assays to facilitate comparison of results and improve decision making on vaccine construct development, product characterisation, down selection of candidates and/or formulation, and clinical development plans.
The project involves thirteen partner institutions and is funded by the European Commission's Framework Program 7 (FP7) as Coordination and Support Action, project number: 223126, with €1 000 000 and by additional complementary contributions from the PATH Malaria Vaccine Initiative and the Centers for Disease Control and Prevention.
The official starting date of the project is 1st April 2009.
EVI has an exciting new Project Manager position. Deadline for applications: 21 June 2013, 17:00.
In addition to the initial groups, TRANSVAC transnational access platform has integrated five additional groups, who provide their services to users on a free and paid basis. Read the TRANSVAC Press release about the new services.
The new services available on a free basis are the MultiBac Platform Service from the European Molecular Biology Laboratory (EMBL, France). Free access has been reserved and made available for vaccine-related projects by the BioSTRUCT-X project/research infrastructure.
Interested users can obtain more information on the paid services on the TRANSVAC website, and can liaise directly with service providers until new funding is available within TRANSVAC. An “advisory scientific review process” is also offered to the applicants who require advice on their project, objectives, and methodology used. This review process is organised in parallel with the review of applications to the free-of-charge services.
Call for Action on Vaccine Development and Immunisation access for those most at need
On 16th April 2012, the European Union (EU) Vaccines Advocacy Coalition (EUVAC) published a Call for Action on Vaccine Development and Immunisation access for those most at need.
EUVAC, of which EVI is part, is a policy driven advocacy and campaigns network that strives to raise the profile of vaccines and ensure the EU institutions address the issue of vaccine development and immunisation access for developing countries.
The specific text can be found on pages 20-21 at http://www.theparliament.com/digimag/immunisation but the whole brochure is worth reading! The Parliament Magazine is widely recognised as the magazine for Members of European Parliament (MEPs), by MEPs.
Nicola Katrin Viebig takes up her duties as Project Manager on 2 May. EVI extends a warm welcome to Nicola, who will be working on projects funded by EDCTP, EC, and EVI.
The European Vaccine Initiative is publishing a Press Release for the PRIMALVAC project, which aims at developing a vaccine to prevent Pregnancy Associated Malaria.
There is currently a vacancy EVI for a Business Assistant, deadline for applications 7 September 2012
To read more about upcoming events
please go to ►Announcements.
For information on past meetings
please go to ►Meetings.
View the project